Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Top Vascular Stents Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Vascular Stents Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Bare-metal Stents
1.3.3 Drug-eluting Stents
1.3.4 Bioabsorbable Stents
1.4 Market Segment by Application
1.4.1 Global Vascular Stents Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospitals & Cardiac Centers
1.4.3 Ambulatory Surgical Centers
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Vascular Stents Production Capacity Analysis
2.1.1 Global Vascular Stents Production Value (2015-2026)
2.1.2 Global Vascular Stents Production (2015-2026)
2.1.3 Global Vascular Stents Capacity (2015-2026)
2.1.4 Global Vascular Stents Marketing Pricing and Trends
2.2 Global Vascular Stents Market Size Growth Potential by Key Producing Regions
2.2.1 Global Vascular Stents Market Size by Key Producing Regions: 2015 VS 2021 VS 2026
2.2.2 Global Vascular Stents Market Share by Key Producing Regions: 2021 VS 2026
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Primary Interviews with Key Vascular Stents Players: Views for Future
3 Market Share by Manufacturers
3.1 Global Top Manufacturers by Vascular Stents Production Capacity
3.1.1 Global Top Manufacturers by Vascular Stents Production Capacity (2015-2020)
3.1.2 Global Top Manufacturers by Vascular Stents Production (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Vascular Stents Production in 2019
3.2 Global Top Manufacturers by Vascular Stents Revenue
3.2.1 Global Top Manufacturers by Vascular Stents Revenue (2015-2020)
3.2.2 Global Top Manufacturers Market Share by Vascular Stents Revenue (2015-2020)
3.2.3 Global Vascular Stents Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vascular Stents as of 2019)
3.4 Global Vascular Stents Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Vascular Stents Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Vascular Stents Market
3.7 Key Manufacturers Vascular Stents Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Estimate and Forecast by Type (2015-2026)
4.1 Global Vascular Stents Historic Market Size by Type (2015-2020)
4.1.2 Global Vascular Stents Production Market Share by Type (2015-2020)
4.1.3 Global Vascular Stents Production Value Market Share by Type
4.1.4 Vascular Stents Average Selling Price (ASP) by Type (2015-2020)
4.2 Global Vascular Stents Market Size Forecast by Type (2021-2026)
4.2.2 Global Vascular Stents Production Market Share Forecast by Type (2021-2026)
4.2.3 Global Vascular Stents Production Value Market Share Forecast by Type
4.2.4 Vascular Stents Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Vascular Stents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Vascular Stents Consumption by Application (2015-2020)
5.2 Global Vascular Stents Consumption by Application (2021-2026)
6 Production by Regions: Market Fact & Figures
6.1 Global Vascular Stents Production (History Data) by Regions (2015-2020)
6.2 Global Vascular Stents Production Value (History Data) by Regions
6.3 North America
6.3.1 North America Vascular Stents Production Growth Rate (2015-2020)
6.3.2 North America Vascular Stents Production Value Growth Rate (2015-2020)
6.3.3 Key Players Market Share in North America
6.3.4 North America Vascular Stents Import & Export (2015-2020)
6.4 Europe
6.4.1 Europe Vascular Stents Production Growth Rate (2015-2020)
6.4.2 Europe Vascular Stents Production Value Growth Rate (2015-2020)
6.4.3 Key Players Market Share in Europe
6.4.4 Europe Vascular Stents Import & Export (2015-2020)
6.5 China
6.5.1 China Vascular Stents Production Growth Rate (2015-2020)
6.5.2 China Vascular Stents Production Value Growth Rate (2015-2020)
6.5.3 Key Players Market Share in China
6.5.4 China Vascular Stents Import & Export (2015-2020)
6.6 Japan
6.6.1 Japan Vascular Stents Production Growth Rate (2015-2020)
6.6.2 Japan Vascular Stents Production Value Growth Rate (2015-2020)
6.6.3 Key Players Market Share in Japan
6.6.4 Japan Vascular Stents Import & Export (2015-2020)
7 Vascular Stents Consumption by Regions: Market Fact & Figures
7.1 Global Vascular Stents Consumption (History Data) by Regions (2015-2020)
7.2 Global Top Vascular Stents Consumers (regions/countries) Ranking and Share of Total Vascular Stents Consumption in 2015 VS 2019
7.3 North America
7.3.1 North America Vascular Stents Consumption by Type
7.3.2 North America Vascular Stents Consumption by Application
7.3.3 North America Vascular Stents Consumption by Countries
7.3.4 U.S.
7.3.5 Canada
7.4 Europe
7.4.1 Europe Vascular Stents Consumption by Type
7.4.2 Europe Vascular Stents Consumption by Application
7.4.3 Europe Vascular Stents Consumption by Countries
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
7.5 Asia Pacific
7.5.1 Asia Pacific Vascular Stents Consumption by Type
7.5.2 Asia Pacific Vascular Stents Consumption by Application
7.5.3 Asia Pacific Vascular Stents Consumption by Regions
7.5.4 China
7.5.5 Japan
7.5.6 South Korea
7.5.7 India
7.5.8 Australia
7.5.9 Taiwan
7.5.10 Indonesia
7.5.11 Thailand
7.5.12 Malaysia
7.5.13 Philippines
7.5.14 Vietnam
7.6 Central & South America
7.6.1 Central & South America Vascular Stents Consumption by Type
7.6.2 Central & South America Vascular Stents Consumption by Application
7.6.3 Central & South America Vascular Stents Consumption by Countries
7.6.4 Mexico
7.6.5 Brazil
7.6.6 Argentina
7.7 Middle East and Africa
7.7.1 Middle East and Africa Vascular Stents Consumption by Type
7.7.2 Middle East and Africa Vascular Stents Consumption by Application
7.7.3 Central & South America Vascular Stents Consumption by Countries
7.7.4 Turkey
7.7.5 Saudi Arabia
7.7.6 U.A.E
8 Company Profiles
8.1 Medtronic Plc
8.1.1 Medtronic Plc Corporation Information
8.1.2 Medtronic Plc Business Overview and Total Revenue (2019 VS 2018)
8.1.3 Medtronic Plc Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.1.4 Vascular Stents Products and Services
8.1.5 Medtronic Plc SWOT Analysis
8.1.6 Medtronic Plc Recent Developments
8.2 Abbott Laboratories
8.2.1 Abbott Laboratories Corporation Information
8.2.2 Abbott Laboratories Business Overview and Total Revenue (2019 VS 2018)
8.2.3 Abbott Laboratories Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.2.4 Vascular Stents Products and Services
8.2.5 Abbott Laboratories SWOT Analysis
8.2.6 Abbott Laboratories Recent Developments
8.3 Boston Scientific Corporation
8.3.1 Boston Scientific Corporation Corporation Information
8.3.2 Boston Scientific Corporation Business Overview and Total Revenue (2019 VS 2018)
8.3.3 Boston Scientific Corporation Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.3.4 Vascular Stents Products and Services
8.3.5 Boston Scientific Corporation SWOT Analysis
8.3.6 Boston Scientific Corporation Recent Developments
8.4 Biotronik Se & Co. Kg
8.4.1 Biotronik Se & Co. Kg Corporation Information
8.4.2 Biotronik Se & Co. Kg Business Overview and Total Revenue (2019 VS 2018)
8.4.3 Biotronik Se & Co. Kg Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.4.4 Vascular Stents Products and Services
8.4.5 Biotronik Se & Co. Kg SWOT Analysis
8.4.6 Biotronik Se & Co. Kg Recent Developments
8.5 B. Braun Melsungen Ag
8.5.1 B. Braun Melsungen Ag Corporation Information
8.5.2 B. Braun Melsungen Ag Business Overview and Total Revenue (2019 VS 2018)
8.5.3 B. Braun Melsungen Ag Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.5.4 Vascular Stents Products and Services
8.5.5 B. Braun Melsungen Ag SWOT Analysis
8.5.6 B. Braun Melsungen Ag Recent Developments
8.6 Terumo Corporation
8.6.1 Terumo Corporation Corporation Information
8.6.3 Terumo Corporation Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.6.3 Terumo Corporation Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.6.4 Vascular Stents Products and Services
8.6.5 Terumo Corporation SWOT Analysis
8.6.6 Terumo Corporation Recent Developments
8.7 Microport Scientific Corporation
8.7.1 Microport Scientific Corporation Corporation Information
8.7.2 Microport Scientific Corporation Business Overview and Total Revenue (2019 VS 2018)
8.7.3 Microport Scientific Corporation Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.7.4 Vascular Stents Products and Services
8.7.5 Microport Scientific Corporation SWOT Analysis
8.7.6 Microport Scientific Corporation Recent Developments
8.8 Meril Life Sciences Pvt. Ltd.
8.8.1 Meril Life Sciences Pvt. Ltd. Corporation Information
8.8.2 Meril Life Sciences Pvt. Ltd. Business Overview and Total Revenue (2019 VS 2018)
8.8.3 Meril Life Sciences Pvt. Ltd. Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.8.4 Vascular Stents Products and Services
8.8.5 Meril Life Sciences Pvt. Ltd. SWOT Analysis
8.8.6 Meril Life Sciences Pvt. Ltd. Recent Developments
8.9 Vascular Concepts Limited
8.9.1 Vascular Concepts Limited Corporation Information
8.9.2 Vascular Concepts Limited Business Overview and Total Revenue (2019 VS 2018)
8.9.3 Vascular Concepts Limited Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.9.4 Vascular Stents Products and Services
8.9.5 Vascular Concepts Limited SWOT Analysis
8.9.6 Vascular Concepts Limited Recent Developments
8.10 C.R. Bard, Inc.
8.10.1 C.R. Bard, Inc. Corporation Information
8.10.2 C.R. Bard, Inc. Business Overview and Total Revenue (2019 VS 2018)
8.10.3 C.R. Bard, Inc. Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.10.4 Vascular Stents Products and Services
8.10.5 C.R. Bard, Inc. SWOT Analysis
8.10.6 C.R. Bard, Inc. Recent Developments
8.11 W.L. Gore and Associates, Inc.
8.11.1 W.L. Gore and Associates, Inc. Corporation Information
8.11.2 W.L. Gore and Associates, Inc. Business Overview and Total Revenue (2019 VS 2018)
8.11.3 W.L. Gore and Associates, Inc. Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.11.4 Vascular Stents Products and Services
8.11.5 W.L. Gore and Associates, Inc. SWOT Analysis
8.11.6 W.L. Gore and Associates, Inc. Recent Developments
8.12 Endologix, Inc.
8.12.1 Endologix, Inc. Corporation Information
8.12.2 Endologix, Inc. Business Overview and Total Revenue (2019 VS 2018)
8.12.3 Endologix, Inc. Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.12.4 Vascular Stents Products and Services
8.12.5 Endologix, Inc. SWOT Analysis
8.12.6 Endologix, Inc. Recent Developments
8.13 Lombard Medical
8.13.1 Lombard Medical Corporation Information
8.13.2 Lombard Medical Business Overview and Total Revenue (2019 VS 2018)
8.13.3 Lombard Medical Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.13.4 Vascular Stents Products and Services
8.13.5 Lombard Medical SWOT Analysis
8.13.6 Lombard Medical Recent Developments
8.14 Translumina Gmbh
8.14.1 Translumina Gmbh Corporation Information
8.14.2 Translumina Gmbh Business Overview and Total Revenue (2019 VS 2018)
8.14.3 Translumina Gmbh Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.14.4 Vascular Stents Products and Services
8.14.5 Translumina Gmbh SWOT Analysis
8.14.6 Translumina Gmbh Recent Developments
8.15 Jotec Gmbh
8.15.1 Jotec Gmbh Corporation Information
8.15.2 Jotec Gmbh Business Overview and Total Revenue (2019 VS 2018)
8.15.3 Jotec Gmbh Vascular Stents Production Capacity, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
8.15.4 Vascular Stents Products and Services
8.15.5 Jotec Gmbh SWOT Analysis
8.15.6 Jotec Gmbh Recent Developments
9 Vascular Stents Production Side by Producing Regions (Countries)
9.1 Global Vascular Stents Production Value Forecast by Region (2021-2026)
9.2 Vascular Stents Production Forecast by Regions
9.3 Key Vascular Stents Producing Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Vascular Stents Consumption Forecast by Top Consumers (Regions/Countries)
10.1 Global Vascular Stents Consumption Forecast by Region (2021-2026)
10.2 North America Market Consumption YoY Growth Forecast
10.2.1 North America Vascular Stents Consumption YoY Growth (2021-2026)
10.2.2 North America Vascular Stents Consumption Forecast by Country (2021-2026)
10.3 Europe Market Consumption YoY Growth Forecast
10.3.1 Europe Vascular Stents Consumption YoY Growth (2021-2026)
10.3.2 Europe Vascular Stents Consumption Forecast by Country (2021-2026)
10.4 Asia Pacific Market Consumption YoY Growth Forecast
10.4.1 Asia Pacific Vascular Stents Consumption YoY Growth (2021-2026)
10.4.1 Asia Pacific Vascular Stents Consumption Forecast by Regions (2021-2026)
10.5 Latin America Market Consumption YoY Growth Forecast
10.5.1 Latin America Vascular Stents Consumption YoY Growth (2021-2026)
10.5.2 Latin America Vascular Stents Consumption Forecast by Country (2021-2026)
10.6 Middle East and Africa Market Consumption YoY Growth Forecast
10.6.1 Middle East and Africa Vascular Stents Consumption YoY Growth (2021-2026)
10.6.2 Middle East and Africa Vascular Stents Consumption Forecast by Country (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Vascular Stents Sales Channels
11.2.2 Vascular Stents Distributors
11.3 Vascular Stents Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
【掲載企業】
Medtronic Plc、Abbott Laboratories、Boston Scientific Corporation、Biotronik Se & Co. Kg、B. Braun Melsungen Ag、Terumo Corporation、Microport Scientific Corporation、Meril Life Sciences Pvt. Ltd.、Vascular Concepts Limited、C.R. Bard, Inc.、W.L. Gore and Associates, Inc.、Endologix, Inc.、Lombard Medical、Translumina Gmbh、Jotec Gmbh
【免責事項】
https://www.globalresearch.jp/disclaimer